GOPC: ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
18 September 2021
|
| In: |
Acta neuropathologica
Year: 2021, Volume: 142, Issue: 6, Pages: 1065-1069 |
| ISSN: | 1432-0533 |
| DOI: | 10.1007/s00401-021-02369-1 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00401-021-02369-1 |
| Author Notes: | Philipp Sievers, Damian Stichel, Martin Sill, Daniel Schrimpf, Dominik Sturm, Florian Selt, Jonas Ecker, Daniel Kazdal, Evelina Miele, Mariëtte E. G. Kranendonk, Bastiaan B. J. Tops, Patricia Kohlhof-Meinecke, Rudi Beschorner, Christof M. Kramm, Martin Hasselblatt, Guido Reifenberger, David Capper, Pieter Wesseling, Albrecht Stenzinger, Till Milde, Andrey Korshunov, Olaf Witt, Stefan M. Pfister, Wolfgang Wick, Andreas von Deimling, David T. W. Jones, Felix Sahm |
| Item Description: | Gesehen am 04.08.2023 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1432-0533 |
| DOI: | 10.1007/s00401-021-02369-1 |